Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04647630

Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit

Prospective Study to Evaluate Streptococcus Pneumoniae Serotypes Prevalence in Community Acquired Pneumonia in Hong Kong Using a Urinary Kit

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,800 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is an epidemiology study for the prevalence and serotypes of pneumococcus pneumoniae in hospitalized patients with community acquired pneumonia (CAP). The serotypes of the pneumococcus pneumoniae will be determined by a urinary antigen assay. This is a single center, non-interventional observatory study.

Detailed description

Patients admitted to the medical wards with a provisional diagnosis under "pneumonia","chest infection" or "fever" will be screened by research assistants. Patients eligible with the inclusion criteria will be recruited into the study. Informed consent will be signed for those patients willing to participate in the study. Patient will be asked to save approximately 40 ml of urine. The urine sample will be processed in local laboratory and shipped out to a commercial lab for detection of any pneumococcal pneumoniae, and if present, serotyping will be performed at the same time using the same urine sample by urinary antigen assay. Meanwhile patients will be managed as usual by their clinical teams. Investigations and treatment will be offered by the clinical team as deemed necessary. The study team will only perform collection of urine and will not interfere the clinical management of the patients. Positive results would be informed to the clinical teams for the appropriate action.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTurine testtest for pneumococcal antigen in urine

Timeline

Start date
2021-01-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2020-12-01
Last updated
2025-02-12

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04647630. Inclusion in this directory is not an endorsement.